Providing Scholarships, Class Reunion Assistance, and More...

AutoGenomics launches expanded check panel to detect 17 B-RAF mutations AutoGenomics.

We congratulate Plexxikon and Roche on the dramatic achievement of their substance PLX-4032, a novel treatment for melanoma and additional cancers harboring the V600E mutation of the B-RAF kinase gene, stated Robert Cole, M.D., Chief Medical Officer at AutoGenomics. Melanoma may be the most serious kind of skin malignancy with about 70,000 new melanoma instances diagnosed every full calendar year in america and about 160,000 world-wide. When diagnosed early melanoma is definitely curable, nevertheless advanced stage disease offers carried now an unhealthy prognosis up to..The differences in major bleeding mortality and events between the two treatments were equivalent at 30 and 180 days. Related StoriesHeart attack sufferers diagnosed and treated for diabetes encounter improved cardiac outcomesSexual activity seldom causes heart attackResearch displays cold weather can increase threat of severe type of heart attackThe price of recurrent heart attack in the fondaparinux group was 9.0 % vs 9.5 % in the LMWH group at 30 days and was 14.2 % vs 15.8 % at 180 days.